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Abstract 
 
Due to their unique physical and chemical properties, gold nanoparticles (AuNPs) are 
promising in a wide variety of biomedical applications. However, there are several 
indications that AuNPs may be toxic and that particle size is an important factor. The 
immune system plays a key role in the biological response to nanoparticles and 
inflammation has been commonly associated with nanoparticle induced toxicity. The main 
objective of this study was therefore to investigate the inflammatory potential of three 
different sizes of AuNPs, in vivo, using the zebrafish embryo model. 
 
Briefly, zebrafish embryos were injected intravascularly with sub-lethal doses (0.1, 0.5 or 
1.0 µg/mL) of 20, 40 or 80 nm citrate stabilized AuNPs at 72h post fertilization (hpf). Three 
replicates of the injected and the control fish were collected at 2, 24 and 48 h post injection 
(hpi) and the expression of proinflammatory (tnfa, il1b, il8, il12a and ifng) and anti-
inflammatory (il10) genes related to the innate immune system were measured by reverse 
transcription-quantitative PCR (RT-qPCR). Survival studies in zebrafish were conducted 
prior to the immune response assessment to determine a sub-lethal dose range, and 
revealed only moderate effects on survival following exposure to 80 nm AuNPs. 
 
Results from the gene expression analysis showed an increased transcription of all the 
inflammatory genes, primarily at 2 hpi, which subsided to control levels by 48 hpi. The 
transcription of the proinflammatory cytokines TNF-α, IL-1β and IFNγ was considerably 
lower for 20 nm AuNPs and might reflect differences related to particle size. The observed 
effects did not seem to be highly correlated with the injected dose, although there was a 
tendency for the highest doses to elicit the highest response. Overall, this study suggests 
that the examined AuNPs induce a transient, inflammatory response in zebrafish.  
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1. Introduction 
 
1.1. Nanoparticles 
 
Nanoparticles (NPs) are defined as structures with one or more dimensions less than 100 
nm. With decreasing particle size, there is an exponential increase in the surface area 
relative to the volume. The increased surface area may affect the chemical reactivity and 
impart unique features to NPs, such as increased strength and electrical conductivity when 
compared to materials on the macroscopic scale (Hornyak et al., 2009). These unique 
properties make NPs highly attractive in nanotechnology, which involves the deliberate 
synthesis and manipulation of nanoparticles (Kessler 2011). 
 
The potential diversity of engineered nanoparticles (ENPs), each with distinct properties is 
enormous when considering the possible variations in shape, size and chemical 
composition and it is becoming increasingly apparent that nanotechnology holds great 
promise for novel applications, especially within biomedicine, electronics and material 
science (Roco et al., 2005a; Piccinno et al., 2012).  However, the same characteristics that 
make ENPs so promising may also influence their behavior in a biological system 
(Donaldson et al., 2004; Oberdorster et al., 2005a). This has raised concerns about the 
safety of NPs, as their nanoscale dimensions may lead to toxic properties that differ from 
bulk-sized material of the same composition (Oberdorster et al., 2005b). 
 
Despite the increased production volume and use of NPs, knowledge about their adverse 
health effects is relatively limited (Roco 2005b). Importantly, several nanomaterials are 
being evaluated for medical use, such gold nanoparticles in targeted drug delivery systems 
(Hurst 2011). The medical applications of NPs represents a modern entry route for NPs 
(Aillon et al., 2009), and the potential toxicity following intentional exposure should be 
examined. 
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1.2 Gold nanoparticles 
 
Gold is a noble, metallic element and is by nature highly inert. In bulk, gold is generally 
considered non-toxic and historically, gold based compounds have been used to treat 
infectious diseases such as tuberculosis and have been used therapeutically to treat 
rheumatoid arthritis (Sigler et al., 1974; Benedek 2004). More recently, due to their high 
stability and the ease to which surface properties (e.g. surface functional groups) can be 
manipulated (Kamat 2002), gold nanoparticles (AuNPs) have become the focus of an 
extensive amount of biomedical research (Hirsch et al., 2003; Huang et al., 2006; Kirpotin 
et al., 2006).  
 
On the nanoscale, the properties of gold are highly influenced by their size and shape 
(Bhattacharya et al., 2008). Of particular interest is that a relatively narrow frequency of 
light can induce oscillations in the de-localized surface electrons (i.e. surface plasmons) of 
AuNPs (Daniel et al., 2004). This phenomenon is called the localized surface plasmon 
resonance (LSPR), which for AuNPs occurs in the visible and near-infrared region (NIR) of 
the electromagnetic spectrum. For spherical AuNPs a single plasmon band is observed in 
the visible region and can readily be observed with gold colloids; as the particle size 
increases, the absorption shifts to longer wavelengths (Kelly et al., 2003) and smaller 
particles (5-20 nm) may appear red in color, while larger particles (80-100 nm) can appear 
purple and brown. 
 
These optical properties can be “fine-tuned” by modifying the size and the shape, and 
constitutes the basis for the biomedical applications of gold nanoparticles (Lee et al., 2006). 
For example, in targeted photothermal therapy, rod–shaped, injectable gold nanoparticles 
are being designed to absorb specific wavelengths in the NIR region. The exited surface 
electrons in the conduction band lose their energy in the form of heat, at temperatures that 
are sufficient to destroy nearby cells (e.g. cancerous cells) (Huang et al., 2006). Other 
biomedical applications of AuNPs include targeted delivery systems, diagnostics and 
medical imaging (Hurst 2011). 
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1.2.1 Synthesis, Size distribution and characterization of gold nanoparticles 
 
Currently, most methods used to synthesize gold nanoparticles follow a similar strategy. In 
these methods dissolved gold salts are reduced in the presence of surface capping agents to 
stabilize the particles and prevent aggregation by electrostatic or physical repulsion 
(Dreaden et al., 2012). The particle size can be controlled by adjusting the ratio of gold ions 
and the reducing agent (Khan et al., 2013). The refined Turkevich method (Turkevich et al., 
1951; Frens 1973) is the simplest and most common method used to synthesize gold 
nanoparticles (Daniel et al., 2004). In this method, chlorauric acid (HAuCl4) is reduced in an 
aqueous solution by utilizing sodium citrate as both the reducing and - capping agent. In 
general, smaller amounts of citrate will result in larger particles. This method is known to 
produce spherical, monodisperse gold nanoparticles (gold colloids) in the size range of 9-
120 nm (Kimling et al., 2006).  
 
Producing AuNPs leads to unique properties that are not found in the bulk material, 
however these benefits may be lost if the particles aggregate. Colloidal stability is known to 
be highly dependent on particle surface charge and environmental conditions such as pH, 
temperature and ionic strength (Fubini et al., 2010), and when introduced into a new test 
system AuNPs have been shown to form agglomerates (Dobrovolskaia et al., 2009; Wang et 
al., 2010). Agglomeration may shift the size distribution towards larger sizes and alter the 
physicochemical properties (i.e. size and surface area) of NPs, which can have important 
implications for their distribution as well as their toxicological properties (Albanese et al., 
2011).  
 
Because the shape, size and the state of agglomeration are important in determining the 
biological fate of nanoparticles, it is recommended that nanoparticles be characterized 
prior to exposure (Powers et al., 2007). Since gold is electron-dense, it is easy to identify 
AuNPs using transmission electron microscopy (TEM). TEM generates highly resolved 
images and is commonly used to gain information about the size distribution and 
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morphology of a sample. However, sample preparation for TEM imaging often involves 
drying, which may result in agglomeration of the sample (Bohnsack et al., 2012). 
Microscopy methods for characterization should therefore be coupled with other methods 
to characterize the particles in the relevant media. Dynamic light scattering (DLS) methods 
are commonly used in nanotoxicological studies and are useful to evaluate the aggregation 
status (Murdock et al., 2008). However, the presence of larger particles may highly 
influence the intensity of the light scattered and may distort the average particle size 
towards larger sizes (Filipe et al., 2010). 
 
Nanoparticle tracking analysis (NTA) is a more recently developed method that may also 
provide information about the aggregation in a sample (Du et al., 2012). The NTA method 
utilizes the properties of both light scattering and random Brownian movements to 
characterize the hydrodynamic diameter of the particles in a liquid suspension. Further, 
the NTA technique follows individual particles, rather than averaging over a sample, and 
has been shown to accurately analyze the size distribution of particle suspensions (Filipe et 
al., 2010). 
 
1.2.2 Distribution of nanoparticles 
 
Many of the applications of AuNPs will eventually result in particles being introduced into a 
biological system (Alkilany et al., 2010), and direct exposure is a regarded as a likely route 
of exposure for AuNPs in humans (Aillon et al., 2009).   
 
Due to their small size, nanoparticles have been shown to gain access to several biological 
compartments that are usually protected from larger particles (Oberdorster et al., 2005a; 
Fubini et al., 2010). For instance, nasally administered titanium dioxide (TiO2) NPs were 
found to directly enter the brain through the olfactory bulb in mice (Wang et al., 2008), 
which has not been observed for bulk-sized TiO2 (Oberdorster et al., 2005a). The exposure 
was associated with significant oxidative damage and inflammation in the brain, which 
raises concerns about the potential neurotoxicity of NPs.  
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Several animal studies have demonstrated the ability of AuNPs to redistribute to various 
organs, such as the liver, spleen, lung, heart and brain, following oral administration and 
various routes of injection (Hillyer et al., 2001; De Jong et al., 2008; Khan et al., 2013). In 
the bloodstream, NPs have been shown to interact with plasma proteins, which may have a 
substantial effect on their cellular uptake, clearance and toxicity (Dobrovolskaia et al., 
2009; Simpson et al., 2010; Lee et al., 2015). Again, nanoparticle characteristics such as 
size, shape, surface charge and agglomeration are among the contributing factors 
determining the interactions with proteins (Monopoli et al., 2011)  
 
The cellular uptake up AuNPs has been found to be highly dependent on size and shape 
(Goodman et al., 2004; De Jong et al., 2008; Chen et al., 2009). Chithrani et al., (2006) 
examined the cellular uptake of a wide size range of citrate stabilized AuNPs in HeLa cells. 
It was determined that endocytosis was most efficient for the medium-sized, 50 nm 
spheres compared to 14 and 74 nm AuNPs. Further, it was shown that the cellular uptake 
of AuNPs was dependent on particle shape, with sphere-shaped particles being much more 
efficiently taken up than their rod-shaped counterparts. For both shapes, the mechanism of 
cellular entry was determined to be receptor mediated endocytosis (RME), through the 
adsorption of non-specific serum proteins.  
 
For purposes of medical applications, AuNPs may be functionalized with surface coatings to 
alter their behavior within a biological system. For example, the adsorption of opsonins, 
proteins that make foreign material visible to phagocytic cells of the immune system 
(Walkey et al., 2012),  has been shown to highly influence the biological fate of NPs 
(Dobrovolskaia et al., 2009). This is because following opsonization, phagocytosis can 
occur, which may lead to the eventual degradation or removal of particles from the 
bloodstream (Owens et al., 2006).  For biomedical applications, this is generally an 
undesired effect and highlights the role of the immune system in removing NPs from the 
host by facilitating excretion through the liver and spleen (Storm et al., 1995; Alexis et al., 
2008). For these reasons, several AuNPs for biomedical use are being synthesized with 
various surface functional groups such as polyethylene glycol (PEG), to prolong systemic 
circulation and to avoid interaction with the immune system (Paciotti et al., 2004). 
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Although the immune cells play an important role in removing them from the body, NPs are 
also taken up by cells from other systems. For example, inhaled TiO2 NPs have been shown 
to accumulate in erythrocytes, which lack phagocytic receptors. In this case, cellular uptake 
was entirely dependent on particle size (Geiser et al., 2005). The internalization of 
nanoparticles have been shown to occur through several different pathways (Kettiger et al., 
2013), including pinocytosis (Shukla et al., 2005) and RME (Chithrani et al., 2006). 
Intracellularly, NPs have been shown to localize in cellular compartments, such as the 
cytosol, lysosomes, endosomes, mitochondria and the nucleus (Berry et al., 2007; AshaRani 
et al., 2009; Kim et al., 2009; Li et al., 2010; Schaeublin et al., 2011), although the various 
uptake mechanisms are unclear.  
 
1.2.3 Inflammation  
 
There is increasing evidence that NPs, due to their increased surface reactivity, induce 
toxicity through the generation of reactive oxygen species (ROS) (Hussain et al., 2005; 
Karlsson et al., 2008; Xia et al., 2008; Pan et al., 2009). In excess, the generation of ROS can 
cause severe damage to cellular components through the oxidation of lipids, proteins and 
DNA and may cause toxicity through the induction of oxidative stress and inflammation 
(Klaasen 2001). 
 
Nanoparticles have been reported to induce ROS production in several different ways. For 
instance, carbon nanotubes have been shown to generate ROS directly due to oxidants on 
the particle surface (He et al., 2011) and AuNPs have been shown to generate ROS through 
the internalization and activation of phagocytic cells in the immune system (Bastus et al., 
2009; Sharma et al., 2013). The innate immune system represents the first line of defense 
in an organism (Mogensen 2009)and has therefore, not surprisingly, been suggested to 
play a key role in the biological response to nanoparticles (Oberdorster et al., 2005a).  The 
nanoparticle induced ROS generation may trigger an immune response through the 
activation of redox sensitive mitogen-activated protein kinases (MAPK) and nuclear factor 
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kappa B (NF-kB) signaling pathways, which are highly involved in regulating the 
production of inflammatory cytokines (Thannickal et al., 2000; Buzea et al., 2007).  
 
Inflammatory cytokines are signaling proteins that primarily are secreted by activated 
immune cells, such as macrophages and neutrophils. Examples are interleukins (IL), 
interferons (IFN) and tumor necrosis factors (TNF). Their main function is to regulate the 
magnitude of the immune response through the balance between proinflammatory 
cytokines, such as TNF-α, IL-1β, IFNγ, and anti-inflammatory cytokines, such as IL-10 (Opal 
et al., 2000; Commins et al., 2010). Inflammation normally promotes healing and is a 
temporary response to injury and infection. However, if not regulated correctly or 
disturbed by a toxic insult, an acute inflammation can in itself cause damage through the 
action of the inflammatory mediators TNF-α and IL-1β which are involved in apoptosis, cell 
proliferation and tissue destruction (Balkwill et al., 2001). Alternatively, the inflammation 
may be driven into a chronic state in which surrounding cells and tissues are continuously 
injured (Licastro et al., 2005). In a human health perspective, inflammation has been linked 
to major diseases such as Alzheimer’s, diabetes and cancer (Balkwill et al., 2001). Because 
cytokines modulate the immune response, they are generally considered as biomarkers for 
immunotoxicity (Elsabahy et al., 2013) and the inflammatory potential of NPs can be 
assessed by measuring transcriptional changes of proinflammatory genes (Yen et al., 
2009). 
 
1.2.4 Toxicity of gold nanoparticles 
 
 In vitro studies have suggested that the potential toxicity of AuNPs  is related to factors 
such as  size, surface charge and shape (Khlebtsov et al., 2011). For instance, Pan et al., 
(2009) investigated the cytotoxic effect of a wide size range of spherical AuNPs (0.8 – 15 
nm) in several mammalian cell lines.  It was found that the 1.4 nm AuNPs triggered 
necrosis and oxidative stress in all the investigated cell lines, whereas 1.2 nm AuNPs 
induced cellular death through apoptotic mechanisms. No cellular damage was observed 
for 15 nm AuNPs, even at the highest concentrations, suggesting a size-dependent toxicity 
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of gold nanoparticles. In addition to size, the surface charge has been shown to influence 
cellular toxicity (Schaeublin et al., 2011; Liu et al., 2013). Cationic AuNPs have been shown 
to display moderate toxicity in COS-1 cells and E. Coli, whereas anionic AuNPs displayed no 
toxicity, perhaps due to interactions with the negatively charged cell membrane (Goodman 
et al., 2004). However, some studies have demonstrated the biocompatibility of AuNPs and 
suggest that they are not cytotoxic. In fact, AuNPs have been demonstrated to have an 
antioxidant effect in RAW264.7 macrophages (Shukla et al., 2005). 
 
The in vivo distribution and toxicity of AuNPs has been shown to be size-dependent in 
rodents following various routes of injection and oral administration (Hillyer et al., 2001; 
De Jong et al., 2008) and the liver has been shown to be an important site of accumulation. 
For example, the results of De Jong et al. (2008) demonstrated that the smallest particle 
size tested (10 nm), had the widest tissue distribution (blood, liver, spleen, kidney, testis, 
thymus, lung and brain) with the highest accumulation of AuNPs observed in the liver and 
spleen of rats. Further, Cho at al., (2009) found that 13 nm PEG coated AuNPs accumulated 
in the liver of mice following intravenous injection, where AuNPs was associated with 
apoptosis and acute liver inflammation. The observed toxicity was associated with a dose-
dependent and transient increase of proinflammatory cytokines (TNF-α, IL-1β). Similar 
results were found by Kahn et al., (2013) in rats exposed to 10 and 50 nm AuNPs. Here, it 
was reported that the 50 nm particles induced the most severe inflammation in the liver, as 
measured by liver pathology and the increase of proinflammatory cytokines (TNF-α, IL-β 
and IL-6). 
 
Several studies have examined the toxicity of AuNPs in zebrafish (Danio rerio), which are 
proving to be a robust vertebrate model for assessing nanotoxicity (Fako et al., 2009). In 
zebrafish, AuNPs have been reported to be moderately toxic when compared to NPs 
composed of elements with higher toxicity, such as silver and copper (Bar-Ilan et al., 2009; 
Asharani et al., 2011; Kovriznych et al., 2013). Others have suggested that AuNPs are toxic 
to zebrafish and have reported embryonic lethality, developmental toxicity (Truong et al., 
2012) and neurotoxicity (Kim et al., 2013). In the mentioned studies, the toxicity of the 
examined AuNPs was highly dependent on the surface charge, with cationic AuNPs being 
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most toxic, Further, the exposure to the charged AuNPs was found to have significant 
effects in the regulation of genes related to the immune system and inflammation (Truong 
et al., 2012). 
 
1.4 The zebrafish (Danio rerio) as a model organism 
 
The zebrafish, Danio rerio (Hamilton 1822), is a small fresh water fish in the minnow family 
(Cyprinidae). They are native to the tropical waters of North-Eastern India and Bangladesh, 
where they are abundant and are commonly found in slow moving streams adjacent to rice 
fields (Engeszer et al., 2007).  
 
The zebrafish has been used for several decades as a vertebrate model for developmental 
biology and molecular genetics (Driever et al., 1996; Haffter et al., 1996). The small size, 
high fecundity and short generation time allows for rapid evaluation of the toxicity of a 
large amount of compounds (Taylor et al., 2010). Compared to other vertebrate models, 
zebrafish are relatively easy to maintain and are cost efficient with regards to husbandry, 
housing and use of chemicals. Newly fertilized embryos are approximately 1 mm in 
diameter and in captivity, adult zebrafish rarely exceed 5 -6 cm. Sexual maturity reaches a 
maximum at 7-18 months of age and under optimal conditions a single pair of zebrafish can 
produce 200-300 embryos each week (Westerfield 2000).  
 
Zebrafish embryonic development is rapid; hatching from the chorion occurs at 42-72 
hours post fertilization (hpf) and the majority of morphogenesis and organogenesis is 
completed by 120 hpf (Kimmel et al., 1995). Furthermore, development takes place ex-
utero and embryos maintain a high degree optical transparency throughout development 
and early larval stages. These features, coupled with the well-described developmental 
stages of zebrafish (Kimmel et al., 1990) enables easy administration of compounds and 
more importantly, the real-time assessment of biological responses. In addition, the 
zebrafish genome has been fully sequenced by the Wellcome Trust Sanger Institute 
(Hinxton, UK) and appears to be highly homogenous to that of humans (Howe et al., 2013). 
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The zebrafish model system offers several advantages in immunological research: they are 
one of the smallest vertebrate models to possess a fully functional innate and adaptive 
immune system, the immune system in zebrafish is highly conserved when compared to 
mammals (Trede et al., 2004; Stein et al., 2007) and there are many molecular tools and 
transgenic lines available to examine interactions and responses of cells in the immune 
system (Brudal et al., 2014). The transparency of the embryos has allowed for studies of 
the immune system at  earlier points in development (Yoder, 2002) and macrophages and 
neutrophils of the innate immune system can be observed as early as 23 hpf and are fully 
functional by 48 hpf (Herbomel et al., 1999). While the innate immune system is present 
early in development, the adaptive immune system is not fully developed in zebrafish until 
3-4 weeks post fertilization (Lam et al., 2004) This separation allows for isolated studies of 
the innate immune system, independently from the adaptive immune system (Traver et al., 
2003). 
1.4.1 Zebrafish as a model for toxicology 
 
More recently, the zebrafish has emerged as an attractive model in toxicology for screening 
of chemicals (Zhang et al., 2003; Zon et al., 2005; Sipes et al., 2011), and nanoparticles 
(Fako et al., 2009). The zebrafish has been shown to exhibit similar physiological responses 
to xenobiotics as mammals (Rubinstein 2006) and have been  especially useful in 
toxicology to screen for developmental toxicants (Selderslaghs et al., 2009) and 
environmental pollutants, such as pesticides and heavy metals (King-Heiden et al., 2012; Jin 
et al., 2015).  
 
There is currently a commitment in the European regulatory framework towards the 
development of alternative models in risk assessment and scientific research (Braunbeck et 
al., 2014). Because zebrafish do not feed externally until 120 hpf (Westerfield 2000), they 
are not subject to the European commission (EC) directive 86/609/EEC, which regulates 
the use of animals in scientific experiments and are, as such considered as an alternative 
model. The zebrafish embryo acute toxicity test (ZFET, OECD TG 236) was recently made 
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available by the Organisation for Economic Co-operation and Development (OECD), as an 
alternative to the fish embryo toxicity test (FET, OECD TG 203), as an attempt to replace 
and reduce the use of juvenile and adult fish in risk assessment (Busquet et al., 2014).  
 
The use of the ZFET test for (eco)nanotoxicological studies is promising, when considering 
the diversity of nanomaterials being produced and the high-throughput screening potential 
of zebrafish (Piccinno et al., 2012; Clemente et al., 2014). Most nanotoxicological studies in 
zebrafish have been performed using waterborne exposure in embryos, which more closely 
resembles natural conditions and is the recommended route of exposure in the ZFET test. 
Dietary exposure is also relevant for NPs, as they may accumulate in food chains (Croteau 
et al., 2011) and has been examined in zebrafish (Park et al., 2010; Geffroy et al., 2012). 
Only a few studies have used microinjection as the primary exposure route (Harper et al., 
2008; Cheng et al., 2009), which is a useful method to precisely deliver a specific amount of 
NPs to distinct anatomical sites. Microinjection may not reflect natural exposure, but can be 
used to efficiently bypass biological barriers such as the chorion or the skin, which is 
relevant for the biomedical applications of NPs (Bohnsack et al., 2012). 
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1.5 Project objectives 
 
Due to size related properties, gold nanoparticles are highly promising in a variety of 
biomedical applications. However, nanoparticles are suggested to induce toxicity trough 
mechanisms associated with inflammation and nanotoxicological studies are as such, 
becoming increasingly relevant. Recently, the zebrafish have emerged as an important 
model organism for evaluating the toxicity of nanoparticles. The main objective of this 
study was therefore to investigate the inflammatory potential of AuNPs using the zebrafish 
as a model system.  
 
We hypothesized that AuNPs of three different sizes would induce an inflammatory 
response in zebrafish embryos, and that the level of this response would be positively 
associated with the dose and the particle size. To test this this hypothesis, zebrafish were 
exposed to sub-lethal doses of 20, 40 and 80 nm AuNPs through intravascular injection and 
the transcription of inflammatory cytokines were measured at 2, 24 and 48 hours post 
injection. AuNPs were characterized prior to exposure and survival assessments in 
zebrafish were performed to determine a sub-lethal dose range. 
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2. Materials and methods 
2.1 Gold nanoparticles 
 
Citrate stabilized gold nanoparticles were purchased commercially at nanoComposix 
Europe (NanoXact TM, Prague, Czech Republic) and were kindly donated to the project by 
Dr. Arno Gutleb from the Luxembourg Institute of Science and Technology (LIST). Stock 
solutions of 20, 40 and 80 nm spherical gold nanoparticles (gold colloid, CAS-no: 7440-57-
5) were received as a 1 mg/ml suspension dissolved in a sodium citrate buffer (>99 % 
water).  The mean diameter of the gold nanoparticles (AuNPs) was specified by the 
manufacturer to be 20 ±3 nm, 40±4 nm and 80±5 nm. The received AuNPs were kept at 4°C 
and away from light for long-term storage until required. For simplicity, the manufacturer 
specified sizes have been used throughout this thesis. 
 
2.1.2 Characterization of gold nanoparticles 
 
Transmission electron microscopy (TEM) (CM100, Phillips, Amsterdam, Netherlands) and 
imaging (Quemesa, Olympus, Tokyo, Japan) was used to characterize the morphology and 
the size distribution of the AuNPs. TEM was performed following established procedures at 
the electron microscopy laboratory at the Department of Biosciences at The University of 
Oslo (UiO). Prior to TEM, the AuNPs were allowed to adsorb to carbon coated formvar 
copper grids. The grids for electron microscopy were briefly placed on one droplet (~20 µl) 
of the AuNP stock solutions and were gently removed after approximately one minute. 
Excess fluid was removed by gently blotting with filter paper and the grids were left to dry 
for 1-2 minutes before imaging. Evaluation of the size distribution was performed by 
manually measuring single AuNPs from the TEM micrographs. The data were then 
transferred and analyzed using Microsoft Excel (2010). 
 
The hydrodynamic diameter and agglomeration of the particles in suspension, i.e. diluted in 
distilled water (dH2O), was evaluated with nanoparticle tracking analysis (NTA). The 
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calculation and analysis of three independent samples of each particle size was performed 
by our partners at LIST using a NanoSight TM instrument (Version 2.3 Build 0033) (Malvern 
Instruments, Amesbury, UK).  
2.2 Zebrafish maintenance and breeding 
 
Zebrafish maintenance and exposure studies were performed at the Model Fish Unit (MFU) 
at the Section for Experimental Biomedicine, Department of Production Animal Clinical 
Sciences, Norwegian University of Life Sciences (NMBU) which has been accredited by the 
Association for Assessment and Accreditation of Laboratory Animal Care International 
(AAALAC) since 2008.  
 
Adult zebrafish were kept in aquarium at 26-30 C, with a 14:10 hour light: dark cycle.  The 
aquarium water, hereafter system water, consisted of 60 mg/L Instant Ocean (Aquarium 
systems, Maryland, USA) in reverse osmosis water at a pH of 7.0  1.0. The physical 
parameters of the system water, such as the pH, the general hardness and ammonium 
levels were recorded on a daily basis, and are important in maintaining a healthy stock of 
fish. 
 
The in-house stocks of adult zebrafish from the AB wild type (wt) strain were bred to 
obtain a sufficient amount of embryos for the exposure studies. Breeding was performed by 
transferring two males and three females to 2 L breeding tanks. A transparent barrier was 
placed in the tank to separate males and females and a small handful of marbles was placed 
in the compartment containing the females to mimic natural spawning grounds. The tanks 
were left overnight and the barriers were removed the following morning. The fish were 
left to spawn for 0.5- 0.45 hours. After the spawning period, fertilized eggs from the 
breeding tanks were collected using a sieve and embryos were pooled together in a petri 
dish (<100 per dish). The collected embryos were immediately rinsed with autoclaved 
system water (embryo water), before they were transferred to new petri dishes. The 
embryos were reared in petri dishes until 120 hours post fertilization (hpf) and incubated 
at 28 °C. Dead individuals were removed and embryo water was changed on a daily basis.  
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2.3 Microinjection in zebrafish 
 
Microinjections in zebrafish were performed using a micromanipulator (Narishige  EG-400, 
Tokyo, Japan) which was connected to a Picospritzer III (Parker Hannfin Corp, Cleveland, 
OH, USA) nitrogen pressure system. Borosilicate needles for injection with a 1 mm outer 
diameter x 0.78 mm inner diameter (Harvard apparatus, Holliston, MA, USA),  were 
prepared with a micropipette puller machine (Flaming/Brown, P-97, Sutter Inc. Novato, CA, 
USA) using program 3 for fine-tipped needles. The needle was loaded with 6 - 10 l of the 
test suspension and then attached to the micromanipulator connected to the pressure 
system. The needles were unsealed by clipping the tip with sharp forceps and trial 
injections were made in mineral oil (Sigma-Aldrich, St. Louis, MO, USA). The diameter of the 
produced droplet was measured with a 1 mm ruler incorporated on a glass slide and the 
settings on the pressure system were adjusted to achieve an injection volume of 
approximately 1 nl for all exposures. 
 
Trial injections in embryos and larvae were conducted prior to the experiments with 1% 
phenol red (Sigma-Aldrich) in phosphate buffered saline (Lonza, Basel, Switzerland) to 
verify that injections were performed correctly. Injections in larvae (48 – 72 hpf) were 
made into the duct of Cuvier for a systemic exposure, and were considered successful if the 
phenol red could be seen in the circulation following injection. 
 
 
 
Figure 1. Microinjection in zebrafish embryo. Phenol red is seen in the systemic circulation following 
injection into the duct of Cuvier. This figure was made by David Westmorland during his master thesis 
in Gareth Griffiths group (UiO). 
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2.4 Survival assessment 
 
Survival of zebrafish exposed to 20, 40 or 80 nm AuNPs was assessed at 100 hpf in 
zebrafish injected at the embryonic stage (2-4 hpf) or at the larval stage (72 hpf) 1.  
 
The stock suspensions of the AuNPs were gently vortexed (IKA ® MS1Shaker, Sigma-
Aldrich) for 10 seconds at low speed prior to dilution. Distilled water (dH2O) was used to 
prepare the particle suspensions to yield experimental concentrations of 5, 50, 100, 500 
and 1000 µg/ml of each particle size. In addition, two controls groups were included and 
consisted of embryos that were injected only with dH2O for comparisons with the AuNP 
treated fish, and a non-injected/untreated control. The latter was included to assess the egg 
quality and to compare the potential effects of the microinjection procedure in the dH2O-
injected groups. Overall, a survival rate of >90% in the negative controls is required for 
valid tests in the fish acute toxicity test (TG 236, OECD).  
 
At 2-4 hpf, zebrafish embryos were placed on 1% agarose plates (VWR, Letterworth, UK) 
and injected directly into the yolk sac with 1 nl of the test solutions. At 72 hpf larvae, from 
the same batch, were anesthetized (as described in section 2.6.2) and injected with 1 nl of 
the particle suspension into the duct of Cuvier. After injections, twenty individuals from 
each treatment group and the controls were transferred to individual wells on a 96-well 
plate. The embryos were distributed between two plates as illustrated in figure 2.2. The 
wells were filled with 250 l of embryo water and were cleaned on a daily basis by 
replacing with 50 % of the embryo media (125 l) with fresh solution. The plates were 
then placed in an incubator and kept at 28 °C.  
 
At 100 hpf, several observations were recorded in larvae and embryo as indicators for 
mortality, including the coagulation of fertilized eggs, lack of heartbeat, no movement and 
                                                 
1 Note that a distinction is made here between embryo and larvae to separate between the two 
developmental time points chosen for the survival studies. Generally, zebrafish up to 120 hpf are referred to 
as embryos. They are described as larvae in this context because they are hatched and swimming at 72 hpf. 
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unresponsive to touch stimuli. The experiment was repeated three times using different 
batches of fish. 
 
 
 
Figure 2. Experimental setup for the survival study. Twenty injected embryos from each treatment 
group and the controls were distributed between two 96-well plates, for each particle size, with each 
well containing one zebrafish. Numbers represent the injected dose in μg/ml; D= distilled water 
control; C= untreated control; dashed line (—) = blank wells.  
 
 
 
 
2.5 Immune response  
 
All procedures regarding the methods for assessing the immune response were performed 
following protocols that were developed at The Department of Pharmaceutical Biosciences 
at the University of Oslo. Microinjections and sampling was performed at MFU, NMBU, 
while the RNA extraction and gene expression analysis (qPCR) was conducted at UiO. 
 
2.5.1 Microinjection of gold nanoparticles 
 
Particle suspensions of 20, 40 and 80 nm AuNPs were prepared prior to exposure (as 
described in section 2.5), to yield experimental concentrations of 0.1, 0.5 and 1.0 g/ml of 
each particle size.  In addition, two control groups were included that consisted of embryos 
injected only with dH2O and an untreated control group.  
 1 2 3 4 5 6 7 8 9 10 11 12 
A D D D D D D D D D D — — 
B 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 — — 
C 500 500 500 500 500 500 500 500 500 500 — — 
D 100 100 100 100 100 100 100 100 100 100 — — 
E 50 50 50 50 50 50 50 50 50 50 — — 
F 5 5 5 5 5 5 5 5 5 5 — — 
G C C C C C C C C C C — — 
H — — — — — — — — — — — — 
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Because the  innate immune system in zebrafish is not fully present until approximately 48 
hpf (Herbomel et al., 1999) and it was decided to inject at 72 hpf for the immune response 
assessment. Microinjection in zebrafish a time consuming procedure and the injection of 
the different particle sizes were therefore performed at separate time points using 
different batches of fish. The choice of concentrations for the immune response was largely 
based on a pilot study that was performed in zebrafish embryo injected with 20 nm AuNPs 
(presented in Appendix B) and were considered as sub-lethal based on prior survival 
assessments. 
 
Zebrafish embryos were anaesthetized at 72 hpf using approximately 3-4 ml buffered 
tricaine methanesulfonate solution (5 mg/mL) (MS 222, Finquel; Argent Laboratories 
Group, Inc. Redmond, WA, USA) in embryo water. The pH of the tricaine solution was 
adjusted to 7.5 0.5 using Trizma® base (Sigma-Aldrich). After 1-2 minutes, anesthetized 
embryos were transferred to 1% agarose plates and any excess water was removed to 
immobilize the fish. Injection of the particle suspensions were made into the duct of Cuvier 
under a stereomicroscope (Wild M10, Leica microsystems GmbH, Wetzlar, Germany), and 
approximately 30 embryos were injected per treatment group. After injections, the 
embryos were transferred new petri dishes, containing fresh embryo water and were kept 
at 28 C until RNA isolation. 
 
2.5.2 Sampling of material for gene expression analysis 
 
Samples for gene expression analysis were collected at 2, 24 and 48 hours post injection 
(hpi). The selection of the time points was chosen to assess the immediate response, and 
the changes in gene expression following exposure. A limit for using zebrafish embryos in 
experiments is set at 120 hpf, which corresponds to 48 hpi in this study.  At each time 
point, nine randomly chosen zebrafish embryos from each treatment group were 
euthanized by an overdose of tricaine solution. Three embryos were pooled into one 
sample, and the total number of replicates for each treatment group and the controls, at 
each time point, was three (Table 1). Embryos were transferred to 1.5 ml Eppendorf tubes 
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(Hamburg, Germany) and the embryo water was immediately removed and replaced by 
200 µl RNAlater (Ambion ® by Life Technologies TM, Carlsbad, CA, USA), which was used to 
stabilize and preserve the RNA in the samples. The samples were kept for long-term 
storage at 4°C until the extraction of RNA. 
 
 
Table 1. Total amount of replicates in each treatment group for the immune 
response. Each replicate consisted of 3 embryos pooled together. The total number 
of zebrafish embryos used in the experiment was therefore 297(=11 treatments x 3 
time points x 3 replicates x 3 individuals)  
 
   Particle size Treatment * 2 hpi 24 hpi 48 hpi 
20 nm AuNPs 0.1 µg/ml 3 3 3 
 
0.5  µg/ml 3 3 3 
 
1.0  µg/ml 3 3 3 
40 nm AuNPs 0.1 µg/ml 3 3 3 
 
0.5  µg/ml 3 3 3 
 
1.0  µg/ml 3 3 3 
80nm AuNPs 0.1 µg/ml 3 3 3 
 
0.5  µg/ml 3 3 3 
 
1.0 µg/ml 3 3 3 
Control dH2O-control  3 3 3 
 
Untreated 3 3 3 
* The injection volume was 1 nl for all exposures  
 
 
2.5.3 Extraction of total RNA 
 
The RNAlater was removed and replaced by 600 µL buffer RLT (provided in RNeasy Mini 
Kit, QIAGEN, GmBH, Hilden, Germany), which was supplemented with 2-mercptoehtanol 
(10 µl/ml) (Invitrogen, Paisley, UK) to eliminate ribonuclease (RNase) released during 
homogenization. Disruption of the samples was performed using a mortar and pestle 
(Sigma-Aldrich) and the lysate was passed a minimum of five times through a 27 gauge x 1 
needle fitted to a 5 ml syringe (BD, Franklin Lakes, NJ, USA). The samples were then 
centrifuged at 15 000 rpm for 3 minutes (Mikro200R, Hettich, Buckinghamshire, UK) and 
the RNA-containing supernatants was transferred into new 1.5 ml Eppendorf tubes and 
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mixed with 600 µL of 70% ethanol (Kemetyl, Vestby, Norway). The samples were loaded 
into RNEasy Mini Spin columns (QIAGEN) and centrifuged for another 15 seconds.  
 
The isolation of the RNA was performed with the RNeasy Mini Kit (QIAGEN ) following the 
manufacture’s protocol (Appendix B: Kit protocols). The process involves a 15-minute 
deoxyribonucease (DNase) treatment, which was performed using an RNase-free DNase set 
(QIAGEN) to remove DNA from the samples. After the DNase treatment, 500 µl buffer RPE 
was added to each spin column and centrifuged in two subsequent steps to remove salts 
from the previous buffer treatments. Spin columns were then transferred to new collection 
tubes and centrifuged for another 2 minutes to remove traces of ethanol.  
 
The spin columns were transferred to new collection tubes and, finally to elute the RNA, 20 
µl Milli-Q water (Merck Millipore, Billerica, MA, USA), was added to each spin column 
membrane, giving a total RNA volume of 20 µl. The RNA quantity and quality in the samples 
were measured with a Picodrop spectrophotometer (PICOPET01, Picodrop Ltd., 
Cambridge, UK) and were analyzed using the Picodrop microlite software (release V2.07). 
The integrity of the isolated RNA was determined by the 260/280 and 260/230 nm 
spectrum ratios, with an acceptance value of ~2.0. The samples were stored at - 80°C until 
reverse transcription reactions.  
2.5.4 Reverse transcription: cDNA synthesis 
 
The reverse transcription (RT) reactions were performed with a High Capacity RNA-to-
cDNA Kit (Applied Biosystems by Life Technologies TM) and a maximum of 9 µl RNA was 
used for each reaction. For each sample 10 µL RT buffer, 1 µl enzyme mix and 9 µl RNase-
free water (provided in the kit) was added to give a total reaction volume of 20 µl. In 
addition, negative controls were included to confirm the absence of DNA contamination in 
the samples. The RT incubation reaction was performed using the GeneAmp PCR System 
(2700 PCR machine, Applied Biosystems) and consisted of 1 hour at 37 °C. The reaction 
was then stopped by heating to 95°C for 5 minutes and held at 4 °C. The cDNA was kept at -
80°C until quantitative PCR (qPCR). 
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2.5.5 Primers and quantitative PCR  
 
Validated zebrafish primers were obtained from commercial suppliers (table 2.7) and were 
chosen to represent a wide range of  inflammatory responses in the zebrafish (Brudal et al., 
2014). TNF-α, IL-1β, IL-8, IL-12a and INFg1-2 were chosen to represent proinflammatory 
cytokines and IL-10 was chosen as an anti-inflammatory cytokine. The reference genes 18S 
rRNA and EF1α were included to normalize the relative transcription levels and have been 
reported to be stable during zebrafish development (Tang et al., 2007). 
 
 
 
The cDNA was diluted in RNase-free water in a 1:10 ratio. A SYBR ® Green (Roche, Basel, 
Switzerland) master mix was prepared for each primer pair (described in Appendix A). For 
each reaction 15 µl master mix and 5 µl diluted cDNA was added, to obtain a total volume 
of 20 µl. Quantitative PCR was performed in triplicates using a LightCycler ® 480 (Roche) 
qPCR machine. The LightCycler was set at the following conditions for the qPCR: 5 minutes 
denaturation at 95 °C, 45 cycles amplification with 10 seconds at 95 °C, 30 seconds at 60 °C 
and 8 seconds at 72 °C. The produced melting peaks and amplification curves were 
analyzed with the LightCycler ® 480 software to evaluate the primer specificity and the 
cycle threshold values, respectively. The absence of multiple peaks observed on the 
Table 2. Selected primers used for qPCR in for the immune response 
Gene name Gene symbol Function Manufacturer * 
18S rRNA zgc: 158463 Reference gene Invitrogen 
Elongation factor 1-alpha ef1a Reference gene Invitrogen 
Tumor necrosis factor a tnfa Proinflammatory QIAGEN 
Interleukin 1, beta il1b Proinflammatory QIAGEN 
Interleukin 8 il8 Anti-inflammatory QIAGEN 
Interleukin 10 il10 Proinflammatory QIAGEN 
Interleukin 12a il12a Proinflammatory QIAGEN 
Interferon, gamma 1-2 ifng1-2 Proinflammatory QIAGEN 
                                                          
 * Forward and revers primers from Invitrogen are provided in separate tubes 
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individual melting curves indicates the primer-specific amplification of the PCR products 
(Figure 2.3 a). 
 
 
 
Figure 3. Representative images from a qPCR run measuring the expression of inflammatory 
cytokines (A) Melting curves indicating primer-specific binding by the absences of multiple peaks in 
the individual samples, and (B) amplification curves reflecting the cycle threshold values 
 
The cycle threshold (Ct) values were analyzed in Microsoft Excel (2010) and represent the 
cycle number at which a signal is detected in the qPCR reaction. In general, a lower Ct value 
indicates a larger amount of cDNA in a sample, and is inversely related to the original 
expression level of the gene in interest (Bustin 2000).   
 
 
 A) 
 B) 
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The relative transcription level for each gene in each sample was determined by 
normalizing the Ct value against the primer efficiency (Brudal et al., 2013) using the 
following equation: 
 
 2^ (Ct max (primer) – Ct (sample))  
 
A normalization factor (NF) was calculated by geometric averaging the mean of the two 
reference genes (Vandesompele et al., 2002) 18S and ef1a.  The relative transcription was 
then normalized against the NF for each sample. The resulting normalized immune 
response data for the AuNP-treated fish was then standardized against the transcription 
levels in the dH2O controls at each time point. 
 
2.6 Statistical analysis 
 
TEM measurements of the size distribution of the gold nanoparticles were evaluated with 
the statistical package R-3.2.0 (The R foundation, Vienna, Austria) using a general linear 
model (GLM) with particle size as the independent variable, and the TEM measurements as 
the dependent variables. 
 
The statistical analysis of survival and immune data was performed using JMP 11 (SAS 
Institute Inc., Cary, NC, USA). The survival of zebrafish at 100 hpf was entered as a 
categorical variable (1= alive, 0= dead). Differences between the treatment groups and the 
control were analyzed using Fisher’s exact test.  
 
The distribution of the immune response data was investigated using Shapiro-Wilks test 
for normality, which revealed a skewed distribution for all the inflammatory genes. The 
log-transformed response, i.e. the transcription of inflammatory genes, gave a satisfactory 
fit to the normal distribution and was therefore used for the statistical analysis of the 
immune response data. General linear models were used, and the log-transformed 
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transcription data of inflammatory genes were dependent variables. Independent, 
categorical variables were exposure concentrations, particle sizes, time points after 
exposure and the interaction between particle size and time points was included in the 
model. Due to the small size of the dataset, it was decided to not investigate other potential 
interactions. The differences between treatment groups and the controls were evaluated 
using the post hoc Tukey’s HSD for multiple comparisons.  
 
Data are presented as the mean ± the standard error of the mean (SEM) and P values <0.05 
are considered as statistically significant, unless stated otherwise. 
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3. Results 
3.1 Characterization of gold nanoparticles 
 
The transmission electron microscopy (TEM) images of 20 nm, 40 nm and 80 nm AuNPs 
showed that the particles were mostly round in shape, with some irregular morphology 
(triangular and oval) seen in all samples. The particles size measured by TEM were 
20.50.4, 39.70.6 and 82.5 1.2 nm (mean  SEM, n= 50) for the 20, 40 and 80 nm AuNPs, 
respectively, and were verified to be from significantly different size distributions (p<0.001 
using GLM). The histograms produced from 50 random measurements showed a slightly 
skewed distribution for all particle sizes (Fig. 5-7).  
 
The mean hydrodynamic diameter of the AuNPs in distilled water was measured by 
nanoparticle tracking analysis (NTA) and  was reported to be 312.6, 503.2, 835.5 nm 
(mean  SEM) for the 20, 40 and 80 AuNPs, respectively. The absence of multiple peaks is 
suggestive of little to no agglomeration in nanoparticle samples (Fig. 4). 
 
 
 
 
 
Figure 4. Size distribution of AuNPs from NTA measurements: (a) 20 nm (b) 40 and (c) 80 nm AuNPs. 
Results are shown as the mean size distribution of three samples and the red line indicates the 
standard error of the mean (SEM). The y-axis is the volume distribution of the AuNPs in 1x 10 -6 per ml 
distilled water. 
 
   A)                B)                                   C)  
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Figure 5. TEM images and histogram of 20 nm AuNPs (a) representative image of the dispersity in the 
sample, the scale bar is 1 m (b) an image at a higher magnification showing particle morphology, the 
scale bar is 0.5 m (c) and histogram of the calculated size distribution (n=50). 
Figure 6. TEM images and histogram of 40 nm AuNPs (a) representative image of the dispersity of the 
sample, the scale bar is 2 m (b) an image at a higher magnification showing particle morphology, the 
scale bar is 0.5 m  (c) and histogram of the calculated size distribution (n=50).  
 
Figure 7. TEM images and histogram of 80 nm AuNPs (a) representative image of the dispersity of the 
sample, scale bar is 2 m (b) an image at a higher magnification showing particle morphology, the 
scale bar is 1 m (c) and histogram of the calculated size distribution (n=50). 
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3.2 Survival assessment 
 
The survival of zebrafish embryos and larvae injected with 20, 40 or 80 nm AuNPs was 
assessed at 100 hours post fertilization. A significant decrease in survival was found in 
embryos exposed to 100, 500 and 1000 µg/ml of 80 nm AuNPs (Figure 7.c). In larvae, a 
significant, positive effect on survival was observed in zebrafish treated with 50 and 100 
µg/ml 20 nm AuNPs (Figure 6.a). Although not statistically significant, a similar positive 
trend was observed in larvae exposed to 80 nm AuNPs.  No significant difference in survival 
was observed between the untreated and dH2O-injected control fish, suggesting that the 
process of injection does not affect survival at 100 hours post fertilization.  
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Survival at 100 hpf of embryo injected at 2 -4 hpf with: (a) 20 nm AuNP (b) 40 nm AuNP and 
(c) 80 nm AuNP. Abbreviations: C=untreated; dH2O= water injected control. Data are presented as the 
mean ± SEM (n=3). ** Significantly different from dH2O control (p<0.05 using Fisher’s exact test) 
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Figure 9. Survival at 100 hpf of larvae injected at 72 hpf with: (a) 20 nm AuNP (b) 40 nm AuNP and 
(c) 80 nm AuNPs. Abbreviations: C=untreated; dH2O= water injected control. Data are presented as the 
mean ± SEM (n=3). Symbols indicate a significant difference from dH2O control (**p<0.05 and *
 p<0.1 
using Fisher’s exact test) 
 
 
3.3 Expression of inflammatory genes 
 
 
Changes in expression of the selected inflammatory genes in zebrafish injected with gold 
nanoparticles were measured at 2, 24 and 48 hours post injection (hpi) by RT-qPCR. The 
relative transcription levels for the investigated genes TNF-α, IL-1β, IL-8, IL-10, IL-12a and 
IFNγ are presented in Fig. 10, and the parameter estimates with p-values from the GLMs of 
the log-transformed responses are presented separately in table 3-8. Overall, the results 
suggest that the gold nanoparticles tested induced changes in the expression of the 
examined inflammatory genes. The expression appeared to be transient, as the mean 
transcription level of all the proinflammatory genes was observed to be close to control 
levels by 48 hpi.  
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Time points 
The results showed a significant increase in transcription of all the inflammatory genes at 2 
hours post injection (Fig. 10) compared to the controls (table 3-8). The highest mean 
transcription levels observed were for TNF-α and IFNγ, while the lowest were observed for 
IL-10 in groups exposed to 80 nm AuNPs. The expression of TNF-α, IL-1β, IL-12a and IFNγ 
exhibited a similar time-course pattern, with expression at 2 hpi being significantly higher 
than at 24 and 48 hpi. However, IL-10 was significantly lower at 24 hpi, compared to 48 
hpi. In addition, IL-8 showed high levels of expression at 24 hpi, being greater than, or 
equal to the levels at 2 hpi for 20 nm and 80 nm, respectively. 
 
Particle size 
An overall significant effect of particle size was observed for TNF- α, IL-1β and IL-10, with 
80 nm AuNPs inducing a higher response compared to 20 nm AuNPs. For IFNγ, similar 
expression levels were observed for 40 and 80 nm AuNPs, with lowest levels observed for 
20 nm.   
 
Exposure concentration 
A significant effect of the dose was observed for all the inflammatory genes (table 3-8), 
with the exception of TNF-α. There was a tendency for the highest dose to elicit the highest 
response. However, this was not consistent at every time point and the results showed no 
significant dose-dependent patterns, although opposite trends were observed at 2 hpi for 
IL-10 and IFNγ in zebrafish exposed to 80 nm AuNPs. 
 
Interaction 
Transcription at the various time points after exposure was different depending on the 
particle size. The transcription of TNF-α, IL-1β and IFNγ was considerably lower in groups 
treated with 20 nm AuNPs at 2 hpi compared to large sized particles. The interaction 
between particle and time was found to be a significant for the expression of TNF-α, IL-1β, 
IL-8 and IFNγ. As is apparent from the adjusted R2 values (Table 3-8), the chosen model 
accounts for only approximately 50 % of the observed variation, which can be explained by 
exclusion of other interactions in the statistical model. 
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Figure 10. Relative expression levels at 2h, 24h and 48h= hours post injection of the selected inflammatory genes 
(a) tumor necrosis factor α (b) interleukin 1β (c) interleukin 8 (d) interleukin 10 (e) interleukin 12a and (f) 
interferon gamma. Zebrafish were injected into the duct of Cuvier at 72 hpf with 0.1, 0.5 or 1.0 µg/ml of 20, 40 or 80 
nm AuNPs. The relative expression was normalized against the two reference genes 18S rRNA and elongation factor 
1-alpha, and were standardized against the transcription level of the dH2O- injected controls at each time point. 
Data are presented as mean ± SEM (n=3). 
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Table 3. Parameter estimates for TNF-α with standard errors (SE), sums of squares (SS) and degrees of 
freedom (df) from the one-way ANOVA for the impact of particle size, dose, time and the interaction 
between particle and time on the log-transformed relative expression of TNF- α in zebrafish injected with 
AuNPs at 72 hpf. Ref. indicates the reference level used within each independent variable, and is arbitrarily 
selected by the statistical program. 
Response Model 
Adjusted 
R2 
df 
Parameter 
estimates 
SE SS p-value 
Relative 
transcription 
LOG TNF-α 
 
Intercept 0.532 
 
-0.243 0.09 
 
0.0082* 
Particle 
size 
20 nm 
 
2 -0.443 0.127 13.06 0.0008* 
 
 
 
40 nm 
  
0.037 
  
0.769 
 
 
 
80 nm 
  
Ref. Ref. 
 
Ref. 
 
 Dose 0 
 
3 0.067 0.155 2.63 0.665 
  
0.1 μg/ml 
  
-0.031 
  
0.84 
  0.5 μg/ml   Ref. Ref.  Ref. 
  
1.0 μg/ml 
  
-0.231 
  
0.14 
 
Time 2 hpi 
 
2 1.155 0.127 81.56 <0.0001* 
  
24 hpi 
  
-0.215 
  
0.093 
  
48 hpi 
  
Ref. Ref 
 
Ref. 
 
Particle 
x Time 
20 nm x 2hpi 
 
4 -0.344 0.18 19.05 0.058 
 
20 nm x 24hpi 
  
0.140 
  
0.435 
  
40 nm x 2hpi 
  
0.366 
  
0.0445* 
  
40 nm x 24hpi 
  
0.380 
  
0.0370* 
 
 
 
Table 4. Parameter estimates for IL-1β with standard errors (SE), Sums of squares (SS) and degrees of 
freedom (df) from the one-way ANOVA for the impact of particle size, dose, time and the interaction 
between particle and time on the log-transformed relative expression of IL-1β in zebrafish injected with 
AuNPs at 72 hpf. Ref. indicates the reference level used within each independent variable, and is arbitrarily 
selected by the statistical program. 
Response Model 
Adjusted 
R2 
df 
Parameter 
estimates 
SE SS p-value 
Relative 
transcription 
Log IL-1β 
 
Intercept 0.433 
 
-0.424 0.071 
 
<.0001* 
Particle 
size 
20 nm 
 2 
0.179 0.101 2.64 0.079 
 
40 nm 
 
 
-0.201 
  
0.0489* 
 
 
80 nm 
  
Ref. Ref. 
 
Ref. 
 
Dose 0 
 
3 0.294 0.123 7.08 0.0194* 
 
 
0.1 μg/ml 
 
 
-0.164 
  
0.187 
  0.5 μg/ml  Ref. Ref.  Ref. 
 
 
1.0 μg/ml 
 
 
0.199 
  
0.11 
 
Time 2 hpi 
 
2 0.587 0.101 35.9 <.0001* 
 
 
24 hpi 
 
 
-0.783 
  
<.0001* 
 
 
48 hpi 
  
Ref. Ref. 
 
Ref. 
 
Particle 
x Time 
20 nm x 2hpi 
 
4 -0.269 0.143 9.23 0.063 
 
20 nm x 24hpi 
 
 
0.362 
  
0.1680* 
 
 
40 nm x 2hpi 
 
 
-0.198 
  
0.168 
 
 
40 nm x 24hpi 
 
 
-0.185 
  
0.198 
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Table 5. Parameter estimates for IL-8 with standard errors (SE), sums of squares (SS) and degrees of 
freedom (df) from the one-way ANOVA assessing the effect of particle size, dose, time and the interaction 
between particle and time on the log-transformed relative expression of IL-1β in zebrafish injected with 
AuNPs at 72 hpf. Ref. indicates the reference level used within each independent variable, and is arbitrarily 
selected by the statistical program. 
Response Model 
Adjusted 
R2 
df 
Parameter 
estimates 
SE SS p-value 
Relative 
transcription 
Log IL-8 
 
Intercept 0.43 
 
0.01 0.073 
 
0.8914 
Particle 
size 
20 nm 
 
2 -0.007 0.104 2.96 0.9442 
 
40 nm 
  
-0.199 
  
0.0589 
 
 
80 nm 
  
Ref. Ref. 
 
Ref. 
 
Dose 0 
 
3 -0.135 0.127 5.8 0.2907 
 
 
0.1 μg/ml 
  
0.205 
  
0.1102 
  0.5 μg/ml Ref. Ref.  Ref. 
 
 
1.0 μg/ml 
  
0.24 
  
0.0629 
 
Time 2 hpi 
 
2 0.53 0.104 39.31 <.0001* 
 
 
24 hpi 
  
0.318 
  
0.0034* 
 
 
48 hpi 
  
Ref. Ref. 
 
Ref. 
 
Particle x 
Time 
20 nm x 2hpi 
 
4 -0.096 0.147 6.42 0.514 
 
20 nm x 24hpi 
  
0.236 
  
0.1124 
 
 
40 nm x 2hpi 
  
0.122 
  
0.4067 
 
 
40 nm x 24hpi 
  
-0.468 
  
0.0020* 
 
 
Table 6. Parameter estimates for IL-10 with standard errors (SE), Sums of squares (SS) and degrees of freedom 
(df) from the one-way ANOVA for the impact of particle size, dose, time and the interaction between particle and 
time on the log-transformed relative expression of IL-10 in zebrafish injected with AuNPs at 72 hpf. Ref. indicates 
the reference level used within each independent variable, and is arbitrarily selected by the statistical program. 
Response Model 
 
Adjusted 
R2 
df 
Parameter 
estimates 
SE SS p-value 
Relative 
transcription 
LOG IL-10 
 
Intercept 0.44 
 
-0.322 0.066 
 
<.0001* 
Particle 
size 
20 nm 
 2 
-0.07 0.094 4.26 0.4607 
 
40 nm 
 
 
-0.20 
  
0.0370* 
  
80 nm 
  
Ref. Ref. 
 
Ref. 
 
Dose 0 
 
3 0.292 0.116 6.45 0.0134* 
  
0.1 μg/ml 
 
 
-0.371 
  
0.0019* 
 0.5 μg/ml  Ref. Ref. 33.25 Ref. 
  
1.0 μg/ml 
  
-0.039 
  
0.7365 
 
Time 2 hpi 
 
2 0.759 0.094 
 
<.0001* 
  
24 hpi 
  
-0.551 
  
<.0001* 
  
48 hpi 
 
 
Ref. Ref. 2.16 Ref. 
 
Particle x 
Time 
20 nm x 2hpi 
 
4 -0.123 0.133 
 
0.3593 
 
20 nm x 24hpi 
  
0.217 
  
0.1084 
  
40 nm x 2hpi 
  
0.124 
  
0.3557 
  
40 nm x 24hpi 
 
 
-0.015 
  
0.9106 
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Table 7. Parameter estimates for IL-12a with standard errors (SE), Sums of squares (SS) and degrees of 
freedom (df) from the one-way ANOVA for the impact of particle size, dose, time and the interaction 
between particle and time on the log-transformed relative expression of IL-12a in zebrafish injected with 
AuNPs at 72 hpf. Ref. indicates the reference level used within each independent variable, and is 
arbitrarily selected by the statistical program. 
Response Model 
Adjusted 
R2 
df 
Parameter 
estimates 
SE SS p-value 
Relative 
transcription 
LOG IL-12a 
 
Intercept 0.58 
 
-0.784 0.084 
 
<.0001* 
Particle 
size 
20 nm 
 
2 0.0251 0.119 0.84 0.8331 
 
40 nm 
 
 
-0.118 
  
0.32 
  
80 nm 
  
Ref. Ref. 
 
Ref. 
 
Dose 0 
 
3 0.699 0.145 18.53 <.0001* 
 
 
0.1 μg/ml 
 
 
-0.384 
  
0.0099* 
  0.5 μg/ml  Ref. Ref.  Ref. 
  
1.0 μg/ml 
 
 
-0.159 
  
0.2771 
 
Time 2 hpi 
 
2 1.375 0.119 104.33 <.0001* 
  
24 hpi 
 
 
-0.515 
  
<.0001* 
  
48 hpi 
  
Ref. Ref. 
 
Ref. 
 
Particle x 
Time 
20 nm x 2hpi 
 
4 -0.096 0.168 2.38 0.5702 
 
20 nm x 24hpi 
 
 
0.258 
  
0.1289 
  
40 nm x 2hpi 
 
 
0.158 
  
0.3479 
 
 
40 nm x 24hpi 
 
 
-0.138 
  
0.4132 
 
 
 
Table 8. Parameter estimates for IFNγ with standard errors (SE), Sums of squares (SS) and degrees of 
freedom (df) from the one-way ANOVA for the impact of particle size, dose, time and the interaction 
between particle and time on the log-transformed relative expression of IFNγ in zebrafish injected with 
AuNPs at 72 hpf. Ref. indicates the reference level used within each independent variable, and is 
arbitrarily selected by the statistical program. 
Response Model 
Adjusted 
R2 
df 
Parameter 
estimates 
SE SS p-value 
Relative 
transcription 
LOG IFNγ 
 
Intercept 0.58 
 
-0.862 0.106 
 
<.0001* 
Particle 
size 
20 nm  2 -0.419 0.15 15.23 0.0063* 
 
40 nm 
  
-0.071 
  
0.6333 
 
80 nm 
  
Ref. Ref. 
 
Ref. 
 
Dose 0 
 
3 0.67 0.184 5.3 0.0004* 
  
0.1 μg/ml 
  
-0.491 
  
0.0089* 
  0.5 μg/ml   Ref. Ref. Ref. 
  
1.0 μg/ml 
  
-0.011 
  
0.95 
 
Time 2 hpi 
 
2 1.595 0.15 59.24 <.0001* 
  
24 hpi 
  
-1.113 
  
<.0001* 
  
48 hpi 
  
Ref. Ref. 
 
Ref. 
 
Particle 
x Time 
20 nm x 2hpi 
 
4 -0.291 0.212 16.68 0.174 
 
20 nm x 24hpi 
  
0.365 
  
0.0887 
  
40 nm x 2hpi 
  
0.590 
  
0.0066* 
  
40 nm x 24hpi 
  
-0.065 
  
0.7584 
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4. Discussion 
The main objective was to determine whether exposure to AuNPs would elicit an 
inflammatory response in zebrafish, and to what extent the particle size would influence 
any response. The results provided support for our hypothesis, since an inflammatory 
response was indeed induced by AuNPs. In addition, moderate differences related to size 
were observed, with 80 nm AuNPs inducing the highest response with regards to survival 
and gene expression. 
 
4.1 Characterization 
 
The citrate stabilized gold nanoparticles (AuNPs) used in this thesis were confirmed to be 
mostly round in shape by TEM and the measured size distributions were within 10 % of the 
particle sizes declared by the supplier (Fig. 5 -6). The average sizes of the AuNPs measured 
by NTA were larger (Fig.  4), which is expected as the method measures the hydrodynamic 
diameter (Browning et al., 2012). However, the 20 and the 40 nm AuNPs were 
approximately 10 nm larger than the target size, which might suggest lower colloidal 
stability of the smaller particles. The NTA results revealed little to no aggregation of AuNPs 
in distilled water, which was indicated by the absence of multiple peaks. Both methods 
used for characterization resulted in size distributions different from the target values and 
highlights the importance of characterization. Size is suggested to play a key role in 
nanotoxicity (Oberdorster et al., 2005a), and as agglomeration may shift the size 
distribution towards larger sizes, it could lead to the misinterpretation of the results.  
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4.2 Zebrafish embryo survival 
 
It has been shown in several studies that zebrafish are susceptible to toxic effects induced 
by nanoparticles (Lee et al., 2007). Our results demonstrated a modest effect on survival, 
with no AuNP-treatment associated with more than 35 % mortality at 100 hpf (Figure 3.2 – 
3.3). This can be considered as moderate, as 10 % mortality is considered normal according 
to the ZFET test (OECD, TG 236) and can be attributed to random effects. Our results are in 
agreement with studies showing gold nanoparticles to be relatively nontoxic (Kovriznych 
et al., 2013), with several reports of low mortality in zebrafish embryos at the highest 
concentrations tested (Bar-Ilan et al., 2009; Asharani et al., 2011). Survival was only found 
to be significantly reduced in embryos exposed at 2-4 hpf to the highest doses of 80 nm 
AuNPs, which was the largest particle size tested. This is in contrast to in vitro findings that 
suggest higher toxicity of smaller sized AuNPs (Pan et al., 2009), which is often suggested 
for nanoparticles due to an increased surface reactivity with decreasing size (Oberdorster 
et al., 2005a; Tedesco et al., 2010; Yeo et al., 2010).  Nevertheless, extrapolation from in 
vitro studies should be done with caution and it is likely that different sized particles exert 
toxicity through different mechanisms of action (Sohaebuddin et al., 2010). However, it was 
recently demonstrated in zebrafish that 82.2 nm AuNPs induce less embryonic lethality and 
developmental abnormalities compared to 11.6 nm AuNPs, when exposed through water 
(Browning et al., 2013). Our conflicting results with regards to larger sized AuNPs may 
reflect differences in the exposure route. Although not substantiated for in this study, our 
results might indicate higher toxicity of larger AuNPs when particles are delivered directly 
into the systemic circulation. 
 
No significant, negative effect on the survival of larvae was found in this study. Embryonic 
stages have been shown to be more sensitive towards the toxic effects of nanoparticles 
compared to later stages (Brun et al., 2014) and AuNPs have been shown induce higher 
mortality in embryos, when compared to larvae in Japanese medaka (Oryzias latipes)(Shin 
et al., 2014). Our findings seem to be in support of these results, as survival was lower in 
embryos exposed to 80 nm AuNPs, compared to larvae exposed to the same doses. In 
addition, we observed opposite trends in embryos and larvae, with results suggesting a 
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positive effect on survival in larvae. However, these results can be explained by the higher 
mortality rates observed in the 20 nm larval control group, with 12 dead larvae recorded in 
one of the replicates. It should be noted that survival was only recorded at 100 hpf and not 
throughout the duration of the experiment. The results from AuNP treated embryos are 
however interesting, and appear to suggest differences in survival related to particle size. 
 
4.3 Expression of inflammatory genes 
 
Our results demonstrate that AuNPs significantly increased the transcription of all the 
inflammatory cytokines measured; TNF-α, IL-1β, IL-8, IL-10, IL-12a and IFNγ, in zebrafish 
at 2 hours post injection (hpi). The expression appeared to be transient, as the 
transcriptional levels were greatly reduced by 24 hpi and were close to control levels by 48 
hpi for all genes, with the exception of IL-10.  A slight increase in the transcription of IL-10 
was observed at 48 hpi, but only in groups injected with 20 and 80 nm AuNPs. IL-10 is also 
known as cytokine synthesis inhibitory factor (CSIF) and is an anti-inflammatory cytokine 
which functions to suppress the transcription of proinflammatory cytokines (Zhang et al., 
2005; Seppola et al., 2008).  Although the differences were minor, the increased 
transcription of IL-10 at 48 hpi is interesting as it was the only anti-inflammatory gene 
included in this assessment and may suggest an immunomodulatory response.  
 
The highest mean expression at 2 hpi was found for TNF-α and IL-1β in 80 nm AuNP 
treated groups and IFNγ for 40 and 80 nm AuNPs. Both TNF-α and IL-1β are considered as 
important indicators of phagocytic activity and they are the first cytokines produced in the 
initial stages of an inflammation, both in fish and in mammals (Roca et al., 2008). IFNγ has 
important antiviral and macrophage activating properties (Altmann et al., 2003), IL-8 is 
important in the recruitment of neutrophils (de Oliveira et al., 2013) and IL-12a functions 
in regulating the production of cytokines (Ito et al., 2008). These are the main 
proinflammatory cytokines produced by activated immune cells in zebrafish (van der Vaart 
et al., 2012) and the expression of the genes observed in our results, may therefore be 
interpreted as the stimulation of an immune response. 
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The time-dependent pattern in cytokine expression observed in this study is consistent 
with findings reported from studies with rodents. TNF-α and IL-1β have been shown to be 
transiently increased in rats injected intraperitoneally with 10 and 50 nm AuNPs (Kahn et 
al., 2013), with 50 nm inducing a more severe inflammation in the liver. In the present 
study, the expression of TNF-α, IL-1β and IFNγ was found to be considerably higher in 
groups exposed to 80 nm AuNPs compared to 20 nm and might indicate differences in 
expression that are related to particle size. The increase of TNF-α, IL-1β, IL-10 and IL-12 
has been associated with acute liver inflammation and apoptosis in rats intravenously 
injected with 13 nm PEG-coated AuNPs (Cho et al., 2009). However, PEG surface coatings 
generally delay immune system recognition of NPs (Walkey et al., 2012) and comparison 
with such studies should be done with caution.  
 
Microarray studies have shown that AuNPs functionalized to carry a charge significantly 
disturbs pathways involved in inflammation and the immune system in zebrafish (Truong 
et al., 2013) and zinc oxide NPs have been shown to induce the transcription of TNF-α, IL-
1β and genes related to oxidative stress in zebrafish (Brun et al., 2014). The AuNPs used in 
in the present study were not functionalized, however, citrate stabilized AuNPs carry a 
slightly negative charge, which is unavoidable due to the methods used to synthesize gold 
colloids (Geffroy et al., 2012).The charge of gold nanoparticles is suggested to play an 
important role in AuNP toxicity (Truong et al., 2012; Kim et al., 2013), even more so than 
the dose, which has been reported to induce insignificant and stochastic developmental 
abnormalities in zebrafish embryo (Browning et al., 2009; Browning et al., 2013). Our 
results revealed no significant dose-dependent effects on transcription. There was a 
tendency for the highest dose to elicit the highest response and a dose-related trend was 
observed for IL-10 and IFNγ, however, these patterns were not consistent at every time 
point and particle size. The injected doses are low, compared with concentrations  
 
The changes in gene expression reported in this study suggest a low inflammatory 
potential of the examined AuNPs, as a transient increase of inflammatory cytokines can be 
considered as a general response to injury in the host defense mechanism (de Oliveira et 
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al., 2013). The recruitment of neutrophils and macrophages are commonly associated with 
tissue injury in zebrafish (Herbomel et al., 1999; Sieger et al., 2009), which could explain 
the increase in cytokine production observed at 2 hpi. However, the transcription of 
cytokines was consistently lower in the control fish injected with dH2O, which suggests that 
the time-dependent pattern observed in the AuNP treated fish is separate from the wound 
inflicted during microinjection. 
4.3.1 Methodical considerations 
 
Reverse transcription quantitative PCR (qPCR) was used to quantify changes in the gene 
expression in zebrafish following AuNP exposure, and is regarded as a sensitive method for 
measuring cytokines, which normally are expressed at low levels (Giulietti et al., 2001). 
There are several important factors to consider when using qPCR in effects assessment, 
including the use of reference genes as internal controls to normalize the transcription 
levels (Vandesompele et al., 2002). Optimally, reference genes should be stably expressed 
in all tissues and be unaffected by the experimental treatment (Bustin 2002). The selected 
reference genes in the present study, 18S rRNA and EF1a have previously been reported to 
be stably expressed during zebrafish development (Tang et al., 2007; McCurley et al., 2008; 
Brudal et al., 2013) and appeared to be unaffected by the AuNP treatment (data shown in 
appendix B.2). An increased expression of EF1a was observed at 48 hpi, however this 
pattern was consistent across all treatments, indicating that this was not an effect of AuNP 
exposure.  
 
It should be noted that a considerable amount of variation was observed in the data, 
making the results difficult to interpret. A problem arises when there are only three 
biological replicates, and cytokine expression in individual zebrafish has been shown to be 
highly variable following bacterial infection (Rojo et al., 2007). Microinjection in 72 hpf 
zebrafish is a time consuming procedure and the amount of biological replicates that can be 
included using this method is therefore limited. For future reference it would be justified, 
and recommended to reduce the number of treatments for the purpose of increasing the 
sample size. 
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RT qPCR has been used successfully to evaluate the immediate and the chronic immune 
response following bacterial infection in zebrafish (Rojo et al., 2007; Brudal et al., 2014) 
and is becoming an established method for evaluating the inflammatory potential of 
nanoparticles, also in zebrafish (Jovanović et al., 2011; Brun et al., 2014). In the present 
study we demonstrated that the zebrafish model could be utilized for evaluating changes in 
the gene expression of inflammatory cytokines following a systemic exposure to AuNPs.  
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5. Conclusion  
The present study  demonstrated a transient increase of the inflammatory cytokines  TNF-
α, IL-1β, IL-8, IL-10, IL12a and IFNγ in zebrafish, primarily at 2 hpi following the systemic 
exposure to 20, 40 and 80 nm citrate stabilized AuNPs, indicating the stimulation of an 
immune response. Differences in gene expression were observed, with 80 nm AuNPs 
inducing higher levels of transcription of the proinflammatory genes TNF-a, IL-1β and 
IFNγ. This provides support to the initial hypothesis that AuNPs induce and immune 
response and that the immune response may be influenced by particle size. 
 
The observed changes in transcription suggest a low inflammatory potential of gold 
nanoparticles, as a transient increase in cytokines may be regarded as a rather general 
immune response. For the biomedical purposes of AuNPs, a low inflammatory potential is 
desired. However, the observed differences related to particle size calls for further 
investigations, and studies on a higher biological level are required to fully evaluate the 
potential toxicity. 
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Future perspectives 
In this study we examined the inflammatory effects of AuNP exposure on the molecular 
level in zebrafish, i.e. at the level of transcription. Studies on the molecular level are 
important to gain insight about the mechanisms of toxicity, but should be coupled with 
assessments on a higher biological level. Future investigations should utilize the potential 
of the various transgenic zebrafish lines that are available for the real-time observation of 
biological responses. Localization and cellular interactions with AuNPs and immune cells 
could be evaluated using transgenic lines that express fluorescence in macrophages and 
neutrophils. It was recently demonstrated in our research group that the AuNPs examined 
in the present study, induce behavioral changes in zebrafish. It would therefore be of 
particular interest to examine NP interactions with microglia cells, which are the resident 
macrophages in the central nervous system, to evaluate whether immune system pathways 
are involved in the observed behavioral effects. Further, to examine effects on survival, the 
immunological impact of developmental exposure to NPs could be assessed by the 
administration of a bacterial challenge, either during development or during a later stage in 
life. 
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Appendix A: Kit protocols 
 
 
A.1 RNeasy Mini Kit (QIAGEN): Purification of Total RNA from Animal Tissues 
 
1-3. Disruption and homogenization of animal tissue 
 
4. Centrifuge the lysate for 3 min at full speed. Carefully remove the supernatant by 
pipetting and transfer it to a new microcentrifuge tube (not supplied). Use only this 
supernatant (lysate) in subsequent steps. In some preparations very small amounts of 
insoluble material will be present after the 3 min centrifugation making the pellet invisible. 
 
5. Add 1 volume of 70% ethanol to the cleared lysate and mix immediately by pipetting. Do 
not centrifuge. Proceed immediately to step 6. 
 
Note: The volume of lysate may be less than 350 or 600µl due to loss during 
homogenization and centrifugation in steps 3 and 4. 
 
Note: Precipitates may be visible after addition of ethanol. This does not affect the 
procedure. 
 
6. Transfer up to 700 µl of the sample including any precipitate that may have formed to an 
RNeasy spin column placed in a 2 ml collection tube (supplied). Close the lid gently and 
centrifuge for 15 s at ≥8000 x g (≥10.000 rpm). Discard the flow-through. 
Reuse the collection tube in step 7. 
If the sample volume exceeds 700 µl. centrifuge successive aliquots in the same RNeasy 
spin column. Discard the flow-through after each centrifugation. 
 
Optional step: DNase treatment 
 
D1. Add 350 µl Buffer RW1 to the RNeasy spin column. Close the lid gently. and centrifuge 
for 15 s at ≥8000 x g (≥10.000 rpm) to wash the spin column membrane. 
Discard the flow-through. 
Reuse the collection tube in step D4. 
D2. Add 10 µl DNase I stock solution (see above) to 70 µl Buffer RDD. Mix by gently 
inverting the tube and centrifuge briefly to collect residual liquid from the sides. 
Buffer RDD is supplied with the RNase-Free DNase Set. 
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Note: DNase is especially sensitive to physical denaturation. Mixing should only be carried 
out by gently inverting the tube. Do not vortex. 
D3. Add the DNase I incubation mix (80 µl) directly to the RNeasy spin column membrane 
and place on the benchtop (20-30° C) for 15 min. 
Note: Be sure to add the DNase I incubation mix directly to the RNeasy spin column 
membrane. DNase digestion will be incomplete if part of the mix sticks to the walls or the 
O-ring of the spin column. 
D4. Add 350 µl Buffer RW1 to the RNeasy spin column. Close the lid gently and centrifuge 
for 15 s at ≥8000 x g (≥10.000 rpm) Discard the flow-through. 
Continue with the first Buffer RPE wash step in the relevant protocol. 
 
Note: In most of the protocols the immediately following Buffer RW1 wash step is skipped 
(as indicated in the protocol). Continue with the first Buffer RPE wash step. 
 
8. Add 500 µl Buffer RPE to the RNeasy spin column. Close the lid gently. and centrifuge for 
15 s at ≥8000 x g (≥10.000 rpm) to wash the spin column membrane. 
Discard the flow-through. 
Reuse the collection tube in step 9. 
Note: Buffer RPE is supplied as a concentrate. Ensure that ethanol is added to Buffer RPE 
before use. 
 
9. Add 500 µl Buffer RPE to the RNeasy spin column. Close the lid gently and centrifuge for 
2min at ≥8000 x g (≥10.000 rpm) to wash the spin column membrane. 
 
The long centrifugation dries the spin column membrane ensuring that no ethanol is 
carried over during RNA elution. Residual ethanol may interfere with downstream 
reactions. 
 
Note: After centrifugation, carefully remove the RNeasy spin column from the collection 
tube so that the column does not contact the flow-through. Otherwise carryover of ethanol 
will occur. 
 
10. Optional: Place the RNeasy spin column in a new 2 ml collection tube (supplied), and 
discard the old collection tube with the flow-through. Close the lid gently, and centrifuge at 
full speed for 1 min. 
Perform this step to eliminate any possible carryover of Buffer RPE, or if residual flow-
through remains on the outside of the RNeasy spin column after step 9. 
 
11. Place the RNeasy spin column in a new 1.5 ml collection tube (supplied). Add 30-50 µl 
RNase-free water directly to the spin column membrane. Close the lid gently and centrifuge 
for 1 min at ≥8000 x g (≥10.000 rpm) to elute the RNA. 
 
 
 
A.2 High Capacity RNA-to-cDNA Kit (Applied Biosystems) 
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1. Use up to 2 g of total RNA per 20 L reaction. 
2. Allow kit components to thaw on ice. 
3. Referring to the table below, calculate the volume of components needed to prepare 
the required number of reactions. 
4. Aliquot RT reaction mix into plates or tubes. 
5. Seal the tubes with appropriate caps. 
6. Place the tubes on ice until you are ready to start the reverse transcription reactions 
7. Incubate the reaction for 37 C for 60 minutes. Stop the reactions by heating to 95 C 
for 5 minutes and hold at 4 C. For convenience the incubation may be performed in 
a thermal cycler. 
8. The cDNA is ready for use in a real-time PCR application or long-term storage in 
freezer (-15 C to -20 C). 
 
 
 
 
 
 
 
 
 
 
 
 
A.3 Master Mix for qPCR reactions 
 
Component volumes for one RT reaction 
Component Component Volume/Reaction (L) 
Manufacturer QIAGEN Invitrogen* 
SYBER green 10.0 10 
Primers 2.0 (F+R) 2.0 F + 2.0 R 
RNase free water 3.0 1.0 
Total per reaction 20.0 20.0 
 
* Forward and revers primers from Invitrogen (18S and EF1a) are provided in separate tubes 
 
 
 
 
 
 
 
 
 
 
Component Component Volume/Reaction (L) 
 +RT reaction - RT reaction 
2X RT Buffer 10.0 10.0 
20X Enzyme Mix 1.0 - 
RNA Sample up to 9 L up to 9 L 
Nuclease-free H2O Q.S.* to 20 L Q.S.* to 20 L 
Total per Reaction 20.0 20.0 
 
* Quantity Sufficient 
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Appendix B: Pilot study and other results  
 
 
B.1 .Pilot Study 
 
 
 
 
 
Figure B.1: Relative transcription levels from the pilot study of the reference genes (EF1a and 18S) 
and the inflammatory genes (TNFa, IL1b, IL8, IL10, IL12a, socs3a and C3b). Results are from one 
replicate and consisted of zebrafish embryos injected with 0.1, 0.5 or 1.0 µg/ml  of 20 nm gold 
nanoparticles into the duct of Cuvier at 72 hpf. PBS was used as the solvent contro 
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B.2. Relative expression of the reference genes 
 
 
 
 
 
Figure B2: Relative expression levels at 2, 24 and 48 h = hours post injection of the reference genes 
that were used to normalize the transcription levels of the immune response.  (a) 18S rRNA and (b) 
EF1a in zebrafish embryos injected with 0.1, 0.5 or 1.0 µg/ml of 20, 40 or 80 nm AuNPs at 72 hpf. Data 
are presented as the mean  SEM. 
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